BOQ - Kitap Yönetim Sistemi
Kitap Bölümü

BAĞIRSAK MİKROBİYOTASINDAN HORMON DENGESİNE: ÖSTROBOLOM VE GÜNCEL DİYET YAKLAŞIMLARI

Berna MADALI
Dr. Öğr. Üyesi, Ankara Yıldırım Beyazıt Üniversitesi
Nurefşan EREN
Necmettin Erbakan Üniversitesi
Saliha UYSAL
Necmettin Erbakan Üniversitesi
Erişim Durumu
Özel Erişim
Yayınlanma Tarihi
30 June 2026
Sayfa Sayısı
120-144
DOI

Özet

Bağırsak mikrobiyotası, metabolik ve immünolojik fonksiyonların yanı sıra hormonal homeostazın düzenlenmesinde de önemli rol oynamaktadır. Son yıllarda, bağırsak mikrobiyotasının östrojen metabolizması üzerindeki etkilerinden sorumlu olan ve östrojen metabolizmasında görev alan bakteriyel genler ile bunların kodladığı enzimlerin bütünü olarak tanımlanan östrobolom kavramı ön plana çıkmıştır. Östrobolom; β-glukuronidaz, β-glukozidaz ve β-galaktosidaz gibi hidrolitik enzimler aracılığıyla östrojenlerin dekonjugasyonunu sağlayarak enterohepatik dolaşımını ve biyoyararlanımını düzenlemektedir. Bağırsak mikrobiyotası ve östrobolomdaki değişiklikler; meme kanseri, emdometrium kanseri ve polikistik over sendromu gibi östrojenle ilişkili hastalıklarla ilişkilendirilmektedir. Beslenmenin; bağırsak mikrobiyotasının yanı sıra, disbiyozis sonucu östrobolom üzerinde değişikliklere neden olarak ve fitoöstrojen gibi bitkisel kaynaklı moleküller aracılığıyla östrojen metabolizmasını etkileyebileceği belirtilmektedir. Konuyla ilgili yapılan çalışmalarda, Akdeniz Diyeti’nin östrobolom disbiyozisini önlemede güçlü bir beslenme stratejisi olduğu bildirilmektedir. Bunun yanı sıra; DASH diyeti, Ketojenik diyet ve mikrobiyota üzerinde etkilerinin olduğu belirtilen bazı yağlı tohumlar (keten tohumu, susam ve kabak çekirdeği gibi), probiyotik-prebiyotikler ve glisemik indeksi düşük besinlerin de östrobolom üzerindeki etkileri değerlendirilmektedir. Fakat buna rağmen östrobolom-beslenme etkileşiminin ve disbiyozun östrojen ilişkili hastalıkların gelişimindeki rolünün daha iyi anlaşılabilmesi için uzun dönemli ve kapsamlı klinik çalışmalara ihtiyaç vardır. Mevcut kanıtlar, bağırsak mikrobiyotasının östrojen homeostazının düzenlenmesinde önemli bir rol oynadığını ve kadın sağlığında hormonal bozukluklar açısından önemli klinik sonuçlara neden olabileceğini göstermektedir.

Anahtar Kelimeler: östrobolom, östrojen, gut mikrobiyotası, diyet

Konu Alanı: Biyoloji -> Biyoloji (diğer) -> Beslenme

Bu Bölüme Atıf Yap
N/A

Balagoni, S., Evelyne, D. G., Mathews, A., Dugyala, R. R., Biradar, M., Deekshith, V., Goel, A., & Verma, A. (2026). Unveiling the Bidirectional Relationship on the Effect of Gut Microbiota and Female Infertility: A Narrative Review. Health Science Reports, 9(5), e72399. https://doi.org/10.1002/hsr2.72399

Benagiano, G., Pluchino, N., Archer, D. F., & Stanczyk, F. Z. (2026). Estrobolome: Is there a missing link? The Journal of Steroid Biochemistry and Molecular Biology, 259, 106967. https://doi.org/10.1016/j.jsbmb.2026.106967

Bucurica, S., Lupanciuc, M., Ionita-Radu, F., Stefan, I., Munteanu, A. E., Anghel, D., Jinga, M., & Gaman, E. L. (2023). Estrobolome and Hepatocellular Adenomas-Connecting the Dots of the Gut Microbial β-Glucuronidase Pathway as a Metabolic Link. International Journal of Molecular Sciences, 24(22), 16034. https://doi.org/10.3390/ijms242216034

Byrne, C. D., & Targher, G. (2015). NAFLD: a multisystem disease. Journal of hepatology, 62(1), S47-S64.

Chaudhary, R., Bansal, N., Sharma, S., Rohilla, M., Chauhan, S., Gupta, S., & Bansal, S. (2026). Mechanistic pathways of estrogen mitigating postmenopausal gut dysbiosis. Molecular Biology Reports, 53(1), 45. https://doi.org/10.1007/s11033-025-11179-7

D’Urso, F., & Broccolo, F. (2024). Applications of Artificial Intelligence in Microbiome Analysis and Probiotic Interventions—An Overview and Perspective Based on the Current State of the Art. Applied Sciences, 14(19), 8627. https://doi.org/10.3390/app14198627

Datkhayeva, Z., Iskakova, A., Mireeva, A., Seitaliyeva, A., Skakova, R., Kulniyazova, G., Shayakhmetova, A., Koshkimbayeva, G., Sarmuldayeva, C., Nurseitova, L., Koshenova, L., Imanbekova, G., Maxutova, D., Yerkenova, S., Shukirbayeva, A., Pernebekova, U., Dushimova, Z., & Amirkhanova, A. (2025). The Multifactorial Pathogenesis of Endometriosis: A Narrative Review Integrating Hormonal, Immune, and Microbiome Aspects. Medicina, 61(5), 811. https://doi.org/10.3390/medicina61050811

Escorcia Mora, P., Valbuena, D., & Diez-Juan, A. (2025). The Role of the Gut Microbiota in Female Reproductive and Gynecological Health: Insights into Endometrial Signaling Pathways. Life (Basel, Switzerland), 15(5), 762. https://doi.org/10.3390/life15050762

Fanizzi, F., D’Amico, F., Zanotelli Bombassaro, I., Zilli, A., Furfaro, F., Parigi, T. L., Cicerone, C., Fiorino, G., Peyrin-Biroulet, L., Danese, S., & Allocca, M. (2024). The Role of Fecal Microbiota Transplantation in IBD. Microorganisms, 12(9), 1755. https://doi.org/10.3390/microorganisms12091755

Fernández-Murga, M. L., Gil-Ortiz, F., Serrano-García, L., & Llombart-Cussac, A. (2023). A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target. Pathogens (Basel, Switzerland), 12(9), 1086. https://doi.org/10.3390/pathogens12091086

Filippone, A., Rossi, C., Rossi, M. M., Di Micco, A., Maggiore, C., Forcina, L., Natale, M., Costantini, L., Merendino, N., Di Leone, A., Franceschini, G., Masetti, R., & Magno, S. (2023). Endocrine Disruptors in Food, Estrobolome and Breast Cancer. Journal of Clinical Medicine, 12(9), 3158. https://doi.org/10.3390/jcm12093158

Foroozanfard, F., Rafiei, H., Samimi, M., Gilasi, H. R., Gorjizadeh, R., Heidar, Z., & Asemi, Z. (2017). The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Clinical Endocrinology, 87(1), 51–58. https://doi.org/10.1111/cen.13333

Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025). The Role of Lifestyle Interventions in PCOS Management: A Systematic Review. Nutrients, 17(2), 310. https://doi.org/10.3390/nu17020310

Hernández-Acosta, J., Tovar, A. R., & Torres, N. (2025). Sex-Specific Diet-Microbiota Interactions in Ageing: Implications for Healthy Longevity. Nutrients, 17(24), 3833. https://doi.org/10.3390/nu17243833

Hou, M.-F., Li, C.-L., Moi, S.-H., Chen, F.-M., Chen, J.-Y., Shih, S.-L., Kan, J.-Y., Yang, S.-F., & Chiang, C.-P. (2026). Longitudinal multiomics analysis of endocrine therapy effects and gut microbiota in breast cancer recurrence. Communications Medicine, 6(1), 117. https://doi.org/10.1038/s43856-026-01384-1

Hu, C., Pai, A. H., Wang, Y., Lu, P., Wu, H., & Huang, H. (2026). Endobiota–Estrobolome Profiles in Reproductive‐Aged Women With Ovarian Endometriosis. Reproductive Medicine and Biology, 25(1), e70061. https://doi.org/10.1002/rmb2.70061

Hu, S., Ding, Q., Zhang, W., Kang, M., Ma, J., & Zhao, L. (2023). Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. Gut Microbes, 15(1), 2236749. https://doi.org/10.1080/19490976.2023.2236749

Jin, J., Yao, G., Zhang, X., Zhang, T., Ye, H., Zhou, X., Yu, Y., Zhao, Y., Qin, Z., Chen, H., Bi, Y., Wang, X., Ren, X., Zhang, Y., Wang, Z., & Zhang, Q. (2026). Gut virome dysbiosis contributes to premature ovarian insufficiency by modulating gut bacteriome. Gut Microbes, 18(1), 2611645. https://doi.org/10.1080/19490976.2025.2611645

Jin, Y., Wang, T., Liao, D., & Jin, X. (2026). Gut Microbiota Has the Potential to Improve Sarcopenic Obesity in Menopausal Women by Regulating Estrogen. International Journal of Women's Health, 18, 589117. https://doi.org/10.2147/IJWH.S589117

Kiesel, L. (2026). The estrobolome and its emerging role in endometriosis pathogenesis: no guts, no story? Gynecological Endocrinology, 42(1). https://doi.org/10.1080/09513590.2026.2652093

Kim, M., Gim, D., Kim, S., Park, S., Eom, T. P., Seol, J., Yeo, J., Jo, C., Seo, G., Ku, H., & Kim, J. H. (2025). From Dysbiosis to Prediction: AI-Powered Microbiome Insights into IBD and CRC. Gastroenterology Insights, 16(3), 34. https://doi.org/10.3390/gastroent16030034

Krishnan N, Narayanan P, Venkatachalam D. P, Velraja S. Role of Diet and Gut Microbiome Composition in Women with Polycystic Ovarian Syndrome (Pcos): A Systematic Review. Nutr Food Sci 2025; 13(2). doi : http://dx.doi.org/10.12944/CRNFSJ.13.2.2

Kumari, N., Kumari, R., Dua, A., Singh, M., Kumar, R., Singh, P., Duyar‐Ayerdi, S., Pradeep, S., Ojesina, A. I., & Kumar, R. (2024). From Gut to Hormones: Unraveling the Role of Gut Microbiota in (Phyto)Estrogen Modulation in Health and Disease. Molecular Nutrition & Food Research, 68(6), 2300688. https://doi.org/10.1002/mnfr.202300688

Larnder, A. H., Manges, A. R., & Murphy, R. A. (2025). The estrobolome: Estrogen‐metabolizing pathways of the gut microbiome and their relation to breast cancer. International Journal of Cancer, 157(4), 599-613. https://doi.org/10.1002/ijc.35427

Li C, Cheng D, Zhang T Ren H and (2025) Unraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health. Front. Endocrinol. 16:1529703. doi: 10.3389/fendo.2025.1529703

Li, P., Shuai, P., Shen, S., Zheng, H., Sun, P., Zhang, R., Lan, S., Lan, Z., Jayawardana, T., Yang, Y., Zhao, J., Liu, Y., Chen, X., El-Omar, E. M., & Wan, Z. (2023). Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: A systematic review and meta-analysis. BMC Medicine, 21(1), 302. https://doi.org/10.1186/s12916-023-02975-8

Liaquat, M., Minihane, A. M., Vauzour, D., & Pontifex, M. G. (2025). The gut microbiota in menopause: Is there a role for prebiotic and probiotic solutions? Post Reproductive Health, 31(2), 105-114. https://doi.org/10.1177/20533691251340491

Lobionda, S., Sittipo, P., Kwon, H. Y., & Lee, Y. K. (2019). The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors. Microorganisms, 7(8), 271. https://doi.org/10.3390/microorganisms7080271

Mahno, N. E., Tay, D. D., Khalid, N. S., Yassim, A. S. M., Alias, N. S., Termizi, S. A., Kasian, J., Mokhtar, N. M., & Ahmad, H. F. (2024). The Relationship Between Gut Microbiome Estrobolome and Breast Cancer: A Systematic Review of Current Evidences. Indian Journal of Microbiology, 64(1), 1-19. https://doi.org/10.1007/s12088-023-01135-z

Muscogiuri, G., Cantone, E., Cassarano, S., Tuccinardi, D., Barrea, L., Savastano, S., Colao, A., & on behalf of the Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group (2019). Gut microbiota: a new path to treat obesity. International Journal of Obesity Supplements, 9(1), 10–19. https://doi.org/10.1038/s41367-019-0011-7

Nagarajan, D. R., Mani Jacob, D., Munir Mufti, M., Rajesh, S., & Dube, R. (2025). Efficacy of Seed Cycling as an Integrative Therapy for Premenstrual Syndrome and Polycystic Ovary Syndrome in Reproductive-Aged Women: A Systematic Review. Cureus, 17(8), e90997. https://doi.org/10.7759/cureus.90997

Nannini, G., Cei, F., & Amedei, A. (2025). Unraveling the Contribution of Estrobolome Alterations to Endometriosis Pathogenesis. Current Issues in Molecular Biology, 47(7), 502. https://doi.org/10.3390/cimb47070502

Nawaz, Y., Munir, S., Aslam, S., Butt, F. R., Tanvir, F., Nawaz, B., Bashir, K., & Tahreem, R. (2026). The Bacterial Role in the Progression of Breast Cancer through Mechanism of Gene Action: Future Prospects with Existing Studies. Current Genomics, 26(6), 458-468. https://doi.org/10.2174/0113892029371937250918105052

Patel, N., Singh D, Lokary V, & Shaker IA. (2023). Polycystic ovarian syndrome and microbiome: Implications for women’s health. 11(1), 47-56. http://dx.doi.org/10.17727/JMSR.2023/11-10

Pérez-Prieto, I., Vargas, E., Salas-Espejo, E., Lüll, K., Canha-Gouveia, A., Pérez, L. A., Fontes, J., Salumets, A., Andreson, R., Aasmets, O., Estonian Biobank research team, Whiteson, K., Org, E., & Altmäe, S. (2024). Gut microbiome in endometriosis: a cohort study on 1000 individuals. BMC medicine, 22(1), 294. https://doi.org/10.1186/s12916-024-03503-y

Peters, B. A., Lin, J., Qi, Q., Usyk, M., Isasi, C. R., Mossavar-Rahmani, Y., Derby, C. A., Santoro, N., Perreira, K. M., Daviglus, M. L., Kominiarek, M. A., Cai, J., Knight, R., Burk, R. D., & Kaplan, R. C. (2022). Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos. mSystems, 7(3), e0027322. https://doi.org/10.1128/msystems.00273-22

Qi, X., Yun, C., Sun, L., Xia, J., Wu, Q., Wang, Y., Wang, L., Zhang, Y., Liang, X., Wang, L., Gonzalez, F. J., Patterson, A. D., Liu, H., Mu, L., Zhou, Z., Zhao, Y., Li, R., Liu, P., Zhong, C., Pang, Y., … Qiao, J. (2019). Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nature Medicine, 25(8), 1225–1233. https://doi.org/10.1038/s41591-019-0509-0

Randeni, N., Bordiga, M., & Xu, B. (2024). A Comprehensive Review of the Triangular Relationship among Diet–Gut Microbiota–Inflammation. International Journal of Molecular Sciences, 25(17), 9366. https://doi.org/10.3390/ijms25179366

Rizk, M. G., & Thackray, V. G. (2020). Intersection of Polycystic Ovary Syndrome and the Gut Microbiome. Journal of the Endocrine Society, 5(2), bvaa177. https://doi.org/10.1210/jendso/bvaa177

Ruiz-Saavedra, S., Zapico, A., González, S., Salazar, N., & de Los Reyes-Gavilán, C. G. (2023). Role of the intestinal microbiota and diet in the onset and progression of colorectal and breast cancers and the interconnection between both types of tumours. Microbiome Research Reports, 3(1), 6. https://doi.org/10.20517/mrr.2023.36

Ruo, S. W., Alkayyali, T., Win, M., Tara, A., Joseph, C., Kannan, A., Srivastava, K., Ochuba, O., Sandhu, J. K., Went, T. R., Sultan, W., Kantamaneni, K., & Poudel, S. (2021). Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment. Cureus. https://doi.org/10.7759/cureus.17472

Salehi, S., Allahverdy, J., Pourjafar, H., Sarabandi, K., & Jafari, S. M. (2024). Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy. Probiotics and Antimicrobial Proteins, 16(5), 1553-1565. https://doi.org/10.1007/s12602-024-10223-5

Saponara, S., Scicchitano, F., D’Alterio, M. N., Chilà, C., Daniilidis, A., Vitale, S. G., & Angioni, S. (2025). Could the estrobolome have a role in endometriosis pathogenesis and infertility? A systematic review. BMC Women’s Health, 26(1), 43. https://doi.org/10.1186/s12905-025-04195-z

Scarfò, G., Daniele, S., Chelucci, E., Papini, F., Epifani, F., Ruggiero, M., Cela, V., Franzoni, F., & Artini, P. G. (2024). Endometrial Dysbiosis: A Possible Association with Estrobolome Alteration. Biomolecules, 14(10), 1325. https://doi.org/10.3390/biom14101325

Senthilkumar, H., Arumugam, M. Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med 23 , 443 (2025). https://doi.org/10.1186/s12967-025-06315-7

Siddiqui, R., Makhlouf, Z., Alharbi, A. M., Alfahemi, H., & Khan, N. A. (2022). The Gut Microbiome and Female Health. Biology, 11(11), 1683. https://doi.org/10.3390/biology11111683

Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. Journal of Clinical Medicine, 12(4), 1454. https://doi.org/10.3390/jcm12041454

Singh, V., Park, Y. J., Lee, G., Unno, T., & Shin, J. H. (2023). Dietary regulations for microbiota dysbiosis among post-menopausal women with type 2 diabetes. Critical Reviews in Food Science and Nutrition, 63(29), 9961–9976. https://doi.org/10.1080/10408398.2022.2076651

Sobstyl, M., Brecht, P., Sobstyl, A., Mertowska, P., & Grywalska, E. (2022). The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer. International journal of molecular sciences, 23(10), 5756. https://doi.org/10.3390/ijms23105756

Sun, Y., Gao, S., Ye, C., & Zhao, W. (2023). Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications. Frontiers in Cellular and Infection Microbiology, 13, 1142041. https://doi.org/10.3389/fcimb.2023.1142041

Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G. (2018). Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism. The Journal of Clinical Endocrinology & Metabolism, 103(4), 1502-1511. https://doi.org/10.1210/jc.2017-02153

Xue, R., Zong, X., Jiang, X., You, G., Wei, Y., & Guo, B. (2026). Artificial Intelligence-Driven Food Safety: Decoding Gut Microbiota-Mediated Health Effects of Non-Microbial Contaminants. Foods, 15(1), 22. https://doi.org/10.3390/foods15010022

Yang, W., Pang, N., & He, X. (2025). Breaking the metabolic-inflammatory vicious cycle in polycystic ovary syndrome: a comparative review of ketogenic and high-fat diets. Lipids in Health and Disease, 24(1), 310. https://doi.org/10.1186/s12944-025-02693-5

Zhu, S., Chen, H., He, B., Zhang, Y., Li, P., & Kuang, J. (2025). Gut microbiota dysbiosis in polycystic ovary syndrome: focus on diet, probiotics, and traditional Chinese medicine. Frontiers in Microbiology, 16, 1659783. https://doi.org/10.3389/fmicb.2025.1659783

Kitap Bölümü (PDF)
BAĞIRSAK MİKROBİYOTASINDAN HORMON DENGESİNE: ÖSTROBOLOM VE GÜNCEL DİYET YAKLAŞIMLARI